首页> 外文期刊>European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery >A hospital discharge risk score for 1-year all-cause mortality or non-fatal cardiovascular events in patients with lower-extremity peripheral artery disease, with and without revascularisation
【24h】

A hospital discharge risk score for 1-year all-cause mortality or non-fatal cardiovascular events in patients with lower-extremity peripheral artery disease, with and without revascularisation

机译:下肢周围动脉疾病伴或不伴血管重建的患者一年全因死亡率或非致命心血管事件的医院出院风险评分

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: This study aims to determine a hospital discharge prognostic risk score for patients with lower-extremity peripheral artery disease (PAD) with and without revascularisation. Design, materials and methods: A prognostic score on mortality or non-fatal cardiovascular events was determined using the database of a multicentre prospective study enrolling consecutive patients hospitalised for PAD (COhorte de Patients ARTeriopathes, COPART). Results: We analysed the data of 640 patients in the derivation cohort and 517 in the validation cohort. The risk score (and corresponding points) included the following factors: age 75-84 years (+2), ≥85 years (+3); previous myocardial infarction (+1); creatinine clearance: ≤30 ml min-1 1.73 m -2 (+1.5), 0.30-0.59 (+1), ankle-brachial index: 0.3 (+2), 0.3-0.49 (+1.5) and 1.3 (+2); C-reactive protein (CRP) ≥70 mg l -1 (+2); and association of statins, anti-platelet agents and renin-angiotensin system inhibitors (-1.5). The frequency of the composite outcome increased significantly with the predicted risk: low risk (≤0 point), 2%; medium (0.5-2 points), 12.8%; high (2.5-4 points), 23%; very high (≥4.5 points): 42.2%. The model had a good performance in terms of discrimination (C-statistic 0.74 and 0.76) and calibration (Hosmer-Lemeshow 0.65). Conclusions: We propose the validated COPART risk score for hospitalised severe PAD. This prognostic risk score is based on six variables easily identifiable in clinical practice. Our study highlights the favourable prognostic impact of the prescription at discharge of combined drug therapies.
机译:目的:本研究旨在确定伴有和不伴有血管重建的下肢周围动脉疾病(PAD)患者的医院出院预后风险评分。设计,材料和方法:使用一项多中心前瞻性研究的数据库确定死亡率或非致死性心血管事件的预后评分,该研究纳入了连续住院的PAD患者(COhorte de Patient ARTeriopathes,COPART)。结果:我们分析了派生队列中640例患者和验证队列中517例患者的数据。风险评分(及相应分数)包括以下因素:年龄75-84岁(+2),≥85岁(+3);先前的心肌梗塞(+1);肌酐清除率:≤30 ml min-1 1.73 m -2(+1.5),0.30-0.59(+1),踝臂指数:<0.3(+2),0.3-0.49(+1.5)和> 1.3(+ 2); C反应蛋白(CRP)≥70 mg l -1(+2);他汀类药物,抗血小板药和肾素-血管紧张素系统抑制剂的相关性(-1.5)。综合结果的发生频率随着预测的风险而显着增加:低风险(≤0点),2%;中(0.5-2分),12.8%;高(2.5-4分),23%;很高(≥4.5分):42.2%。该模型在区分度(C统计量0.74和0.76)和校准(Hosmer-Lemeshow 0.65)方面具有良好的性能。结论:我们建议对住院的严重PAD进行COPART风险评分的验证。该预后风险评分基于在临床实践中易于识别的六个变量。我们的研究突出了处方药在联合药物治疗中的有利预后影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号